Jones Financial Companies Lllp Abbott Laboratories Transaction History

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Abbott Laboratories stock. As of the latest transaction made, Jones Financial Companies Lllp holds 266,684 shares of ABT stock, worth $30.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

266,684

Previous 250,183 6.6%

Holding current value

$30.5 Million

Previous $26 Million 16.96%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $1.65 Million - $1.95 Million	16,501 Added 6.6%	266,684 $30.4 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $6 Million - $6.69 Million	59,540 Added 31.23%	250,183 $26 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $812,090 - $896,918	7,415 Added 4.05%	190,643 $21.7 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $369,779 - $452,640	4,100 Added 2.29%	183,228 $20.2 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $167,941 - $201,501	-1,758 Reduced 0.97%	179,128 $17.3 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $2.7 Million - $3.01 Million	26,792 Added 17.39%	180,886 $19.7 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $300,169 - $353,316	-3,099 Reduced 1.97%	154,094 $15.6 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $257,802 - $302,442	2,712 Added 1.76%	157,193 $17.3 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $234,352 - $271,336	2,422 Added 1.59%	154,481 $14.9 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $422,467 - $510,628	-4,139 Reduced 2.65%	152,059 $16.5 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $28,619 - $34,899	251 Added 0.16%	156,198 $18.5 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $2,195 - $2,687	-19 Reduced 0.01%	155,947 $21.9 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $154,341 - $170,746	-1,323 Reduced 0.84%	155,966 $18.4 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $91,719 - $107,967	-867 Reduced 0.55%	157,289 $18.2 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $260,454 - $306,854	2,393 Added 1.54%	158,156 $19 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $233,940 - $254,927	2,228 Added 1.45%	155,763 $17.1 Million
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $627,734 - $762,336	-6,850 Reduced 4.27%	153,535 $16.7 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $742,728 - $950,600	-9,700 Reduced 5.7%	160,385 $14.7 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $723,309 - $1.06 Million	11,514 Added 7.26%	170,085 $13.4 Million
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $67,989 - $75,688	866 Added 0.55%	158,571 $13.8 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $133,399 - $144,646	-1,630 Reduced 1.02%	157,705 $13.2 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $174,984 - $204,085	2,401 Added 1.53%	159,335 $13.4 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $58,141 - $70,292	-878 Reduced 0.56%	156,934 $12.5 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $637,636 - $722,350	-9,726 Reduced 5.81%	157,812 $11.4 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $78,931 - $95,221	1,298 Added 0.78%	167,538 $12.3 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $9.12 Million - $10.1 Million	158,493 Added 2045.86%	166,240 $10.1 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $8.4 Million - $9.49 Million	-149,204 Reduced 95.06%	7,747 $464,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $19,968 - $21,378	-372 Reduced 0.24%	156,951 $8.96 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $73,772 - $82,337	1,535 Added 0.99%	157,323 $8.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	155,788	155,788 $7.57 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Account

Jones Financial Companies Lllp Abbott Laboratories Transaction History